[Pyrrolidine acetamide as an auxiliary drug in the treatment of cerebral palsy].
Twenty children, with the diagnosis of cerebral palsy (CP) and under classical, physiotherapeutical and pedagogical, treatment, received piracetam (pyrrolidine acetamide) as an auxiliary drug. The goal was to better spasticity, learning and nervous instability problems aiming at better results of over-all treatment of CP. The group that received the drug has been compared to a control group of 20 children treated by the customary treatment only. The comparison showed favourable results for the medicated group. The drug was administered in the dose of 80 mg/kg/day during 10 weeks. The criteria for evaluation have been psychological, clinical, physiotherapeutical and pedagogical. The drug has been given in a new form of presentation: 6% solution for oral use.
D000284:Administration, Oral; D002547:Cerebral Palsy / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D012996:Solutions
D011759:Pyrrolidines; D012996:Solutions
A acetamida de pirrolidona como medicação auxiliar no tratemento da paralisia cerebral